Recon: Merck’s COVID pill used widely despite concerns; ICMRA uninvites Russian regulator from meetings for ‘foreseeable future’
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy